Axonics (MEX:AXNX) Beginning Cash Position : MXN1,950 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Axonics Beginning Cash Position?

Axonics's Beginning Cash Position for the quarter that ended in Mar. 2024 was MXN1,950 Mil.

Axonics's quarterly Beginning Cash Position declined from Sep. 2023 (MXN2,532 Mil) to Dec. 2023 (MXN2,501 Mil) and declined from Dec. 2023 (MXN2,501 Mil) to Mar. 2024 (MXN1,950 Mil).

Axonics's annual Beginning Cash Position declined from Dec. 2021 (MXN4,948 Mil) to Dec. 2022 (MXN4,306 Mil) and declined from Dec. 2022 (MXN4,306 Mil) to Dec. 2023 (MXN4,054 Mil).

Axonics Beginning Cash Position Historical Data

The historical data trend for Axonics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Beginning Cash Position Chart

Axonics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

1,854.05

3,403.16

4,947.59

4,306.24

4,054.23

Axonics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															4,305.20	4,116.34	2,531.71	2,500.70	1,950.47

Axonics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Axonics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Axonics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Axonics (MEX:AXNX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (MEX:AXNX) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

AXNX:USA

Address

26 Technology Drive, Irvine, CA, USA, 92618

Website

https://www.axonics.com

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.